Case | Reference | Age | Race | Disease | CD20 | CD4 | CD8 | TCRa | IgHb | CTxc | MoAbd | Outcome |
1 | Rahemtullah et al. | 77M | Caucasians | PTCL-U | dim | + | - | + | - | Y | Rituximab | Undergoing treatment (4M) |
2 | Rahemtullah et al. | 36F | Caucasians | PTCL-U | dim | + | - | + | - | Y | Rituximab | CR → Relapse → Dead (16M) |
3 | Rahemtullah et al. | 75M | Caucasians | PTCL-U | + | - | - | + | - | Y | Rituximab | Relapse(10M) |
4 | Magro et al. | 65F | Caucasians | Cutaneous PTCL | + | NR | + | + | + | Y | Rituximab | Relapse(2Y) |
5 | Buckner et al. | 84M | Caucasians | PTCL-U | dim | + | NR | + | NR | Y | Rituximab | Dead(6M) |
6 | Cumiskey et al. | 84M | Caucasians | PTCL-U | + | + | NR | + | - | Y | Rituximab | CR |
7 | Makita et al. | 59M | Orientals | PTCL-NOS | + | - | - | + | - | Y | Rituximab | PR → Relapse → Dead (16M) |
8 | Hirata et al. | 74M | Orientals | PTCL-NOS | + | + | - | + | - | Y | Rituximab | CR → Relapse → Dead (1Y) |
9 | This case | 82M | Orientals | PTCL-NOS | + | - | - | + | - | Y | Mogamulizumab | CR(24M) |